Home 5 Articles 5 New Study Shows Viability of Using Ancestry to Compare Prostate Cancer Risk Across Populations

New Study Shows Viability of Using Ancestry to Compare Prostate Cancer Risk Across Populations

by | Feb 11, 2021 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies

Ancestry has been shown to be a risk factor for prostate cancer. Unfortunately, we know very little about why men of certain races and ethnicities are more prone to get it, let alone how to use genetic information about ancestry to stratify risk across different populations. But according to a new report, a genetic risk score based on a multi-ancestry meta-analysis can stratify men by their risk of developing prostate cancer. The Diagnostic Challenge Black men in the U.S., and other men of African ancestry, are diagnosed with prostate cancer more than men of other races. By the same token, prostate cancer occurs less often in Asian-American and Hispanic/Latino men than in non-Hispanic whites. Ancestry affects not just susceptibility but the age a man is likely to get prostate cancer and whether he is likely to die from it. However, the reasons for these ancestry-based variants remains a mystery. New Genetic Clues Genome analysis may hold the key to unraveling this mystery. There are currently a total of 183 known genetic risk variants for prostate cancer. On Jan. 4, Nature Genetics reported that an international team of researchers had uncovered 86 more. According to the report, the team did this […]

Sign up for our free weekly Lab & Pathology Insider email newsletter

Subscribe to Clinical Diagnostics Insider to view

Start a Free Trial for immediate access to this article